Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSelective antagonism of anticancer drugs for side-effect removal
Trends in Pharmacological Sciences, 07/15/09
Fernandez A et al. - The authors propose a mode of 'therapeutic editing' where one drug suppresses the side effect promoted by the primary drug as it impacts off-target cells. Editor and primary drug have overlapping therapeutic impact, and the editor suppresses the downstream propagation of toxicity-related signaling.
Related Articles
Anticancer Chemotherapy Inhibits MHC Class I–Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Cancer Research, 10/21/09
Relevance Score: 65%
To Tell or Not to Tell: The Community Wants to Know About Expensive Anticancer Drugs As a Potential Treatment Option
Journal of Clinical Oncology, 10/06/09
Relevance Score: 65%
Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09
Relevance Score: 65%
The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09
Relevance Score: 64%
Brain damage from anticancer treatments in adults
Current Opinion in Oncology, 10/13/09
Relevance Score: 64%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain
Current Medical Research and Opinion, 12/07/09
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES)
International Journal of Andrology, 12/04/09
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Chemotherapy alone for organ preservation in advanced laryngeal cancer
Head & Neck, 12/07/09
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
Annals of Oncology, 12/04/09
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor